-
Needham & Company LLC Reiterates "Buy" Rating for Stoke Therapeutics (NASDAQ:STOK)
Source: Buzz FX / 19 Feb 2025 15:17:13 America/Chicago
Needham & Company LLC Reiterates "Buy" Rating for Stoke Therapeutics (NASDAQ:STOK) Written by MarketBeat February 19, 2025 Share Link copied to clipboard. Stoke Therapeutics ( NASDAQ:STOK - Get Free Report ) 's stock had its "buy" rating re
Read more...